These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18383437)

  • 1. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
    Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
    J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a novel class of antithrombotic compounds with dual function. Discovery of 1,4-benzoxazin-3(4H)-one derivatives possessing thrombin inhibitory and fibrinogen receptor antagonistic activities.
    Stefanic Anderluh P; Anderluh M; Ilas J; Mravljak J; Sollner Dolenc M; Stegnar M; Kikelj D
    J Med Chem; 2005 May; 48(9):3110-3. PubMed ID: 15857114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acids and peptides. XVIII. Synthetic peptides related to N-terminal portion of fibrin alpha-chain and their inhibitory effect on fibrinogen/thrombin clotting.
    Kawasaki K; Miyano M; Hirase K; Iwamoto M
    Chem Pharm Bull (Tokyo); 1993 May; 41(5):975-7. PubMed ID: 8339344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin.
    Maraganore JM; Bourdon P; Jablonski J; Ramachandran KL; Fenton JW
    Biochemistry; 1990 Jul; 29(30):7095-101. PubMed ID: 2223763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19.
    Girnys EA; Sobczyk-Kojiro K; Mosberg HI
    Chem Biol Drug Des; 2010 Jan; 75(1):35-9. PubMed ID: 19954432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peptides as inhibitors of thrombin coagulation activity and of thrombocyte aggregation].
    Pastorova VE; Liapina LA; Cherkasova KA; Ashmarin IP
    Usp Fiziol Nauk; 1999; 30(2):80-91. PubMed ID: 10420478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
    Plow EF; Pierschbacher MD; Ruoslahti E; Marguerie GA; Ginsberg MH
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8057-61. PubMed ID: 3877935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution NMR studies of fibrinogen-like peptides in solution: interaction of thrombin with residues 1-23 of the A alpha chain of human fibrinogen.
    Ni F; Konishi Y; Frazier RB; Scheraga HA; Lord ST
    Biochemistry; 1989 Apr; 28(7):3082-94. PubMed ID: 2742826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acids and peptides. XVI. Synthesis of N-terminal tetrapeptide analogs of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting.
    Kawasaki K; Hirase K; Miyano M; Tsuji T; Iwamoto M
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3253-60. PubMed ID: 1294328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the chiral space within the active site of alpha-thrombin with a constrained mimic of D-Phe-Pro-Arg--design, synthesis, inhibitory activity, and X-ray structure of an enzyme-inhibitor complex.
    Hanessian S; Balaux E; Musil D; Olsson LL; Nilsson I
    Bioorg Med Chem Lett; 2000 Feb; 10(3):243-7. PubMed ID: 10698445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel morpholinone-based D-Phe-Pro-Arg mimics as potential thrombin inhibitors: design, synthesis, and X-ray crystal structure of an enzyme inhibitor complex.
    Dahlgren A; Johansson PO; Kvarnström I; Musil D; Nilsson I; Samuelsson B
    Bioorg Med Chem; 2002 Jun; 10(6):1829-39. PubMed ID: 11937341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
    Odake S; Kam CM; Powers JC
    J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of enzymatic hydrolysates of collagen and collagen-related synthetic peptides on fibrinogen/thrombin clotting.
    Maruyama S; Nonaka I; Tanaka H
    Biochim Biophys Acta; 1993 Jul; 1164(2):215-8. PubMed ID: 8329452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
    Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Evaluation of Spumigin Analogues Library with Thrombin Inhibitory Activity.
    Žula A; Będziak I; Kikelj D; Ilaš J
    Mar Drugs; 2018 Oct; 16(11):. PubMed ID: 30373260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based understanding of ligand affinity using human thrombin as a model system.
    Nienaber VL; Mersinger LJ; Kettner CA
    Biochemistry; 1996 Jul; 35(30):9690-9. PubMed ID: 8703940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity.
    Jetten M; Peters CA; Visser A; Grootenhuis PD; van Nispen JW; Ottenheijm HC
    Bioorg Med Chem; 1995 Aug; 3(8):1099-114. PubMed ID: 7582983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.